Peptide Atlas · Mineral

Ferric derisomaltose (iron isomaltoside 1000)

In the IRONMAN trial of 1,137 patients with heart failure and iron deficiency, intravenous ferric derisomaltose lowered recurrent heart failure admissions and cardiovascular death against usual care (rate ratio 0.82), short of statistical significance except in a pre-specified COVID-19 sensitivity analysis.

established

provisional
2 citations
0 discussions
0 followers
Monofer
Monoferric
ferric derisomaltose
iron isomaltoside 1000

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

No protocol has enough distinct humans behind it to be a protocol. One person saying it twice is still one person.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.